Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-80002 |
Brand: | MCE |
CAS: | 1431525-23-3 |
MDL | MFCD25372042 |
---|---|
Molecular Weight | 524.59 |
Molecular Formula | C29H24N4O4S |
SMILES | O=C1N(C2=C(C=C1)C=NC3=CC=C(C4=CC=C(NS(=O)(C)=O)C=C4)C=C32)C5=CC=C(C)C(NC(C=C)=O)=C5 |
BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys 496 in the BMX ATP binding domain with an IC 50 of 8 nM, also targets the related Bruton’s tyrosine kinase (BTK) with an IC 50 value of 10.4 nM, but is more than 47-656-fold less potent against Blk, JAK3 , EGFR , Itk , or Tec activity.
IC50: 8 nM (BMX), 10.4 nM (BTK)
BMX-IN-1 inhibits the proliferation of Tel-BMX-transformed Ba/F3 cells and RV-1 cells with IC 50 s of 25 nM and 2.53 μM. BMX-IN-1 exhibits remarkable selectivity with an S(10) score of 0.01. BMX-IN-1 inhibits only wild-type BMX with an IC 50 of 138 nM. BMX-IN-1 requires covalent modification of Cys 496 of BMX to achieve potent inhibition [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMF : 10 mg/mL ( 19.06 mM ; Need ultrasonic)
DMSO : 8.33 mg/mL ( 15.88 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.9063 mL | 9.5313 mL | 19.0625 mL |
5 mM | 0.3813 mL | 1.9063 mL | 3.8125 mL |
10 mM | 0.1906 mL | 0.9531 mL | 1.9063 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.